Filing Details

Accession Number:
0001638599-17-000668
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-30 16:33:56
Reporting Period:
2017-06-29
Filing Date:
2017-06-30
Accepted Time:
2017-06-30 16:33:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1676906 David Siewers C/O Selecta Biosciences, Inc.
480 Arsenal Way
Watertown MA 02472
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-29 3,846 $0.47 3,882 No 4 M Direct
Common Stock Acquisiton 2017-06-29 5,770 $0.63 9,652 No 4 M Direct
Common Stock Disposition 2017-06-29 9,616 $20.00 36 No 4 S Direct
Common Stock Disposition 2017-06-29 36 $20.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2017-06-29 3,846 $0.00 3,846 $0.47
Common Stock Employee Stock Option (right to buy) Disposition 2017-06-29 5,770 $0.00 5,770 $0.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-09-19 No 4 M Direct
9,614 2020-09-06 No 4 M Direct
Footnotes
  1. The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
  2. The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the set forth herein.
  4. The 36 shares sold were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
  5. All shares underlying this option are fully vested.